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Renal secretion of organic anions and cations. The renal proximal
tubule actively transports charged, potentially toxic xenobiotics from
blood to lumen. Basolateral uptake of organic anions is indirectly coupled
to the sodium gradient through Na-dicarboxylate cotransport and dicar-
boxylate-organic anion exchange. Upon entry, a significant fraction of
intracellular organic anion is sequestered within vesicles. Disruption of the
cellular microtubular network can lead to both diminished vesicular
movement and reduced transepithelial secretion. Luminal efflux of organic
anions is energetically downhill, but carrier mediated. Both anion ex-
change and potential driven transport are present, but neither completely
accounts for transport from cell to lumen. For organic eations, basolateral
entry is downhill via potential driven facilitated diffusion. Intracellular
sequestration of organic cations in vesicles is substantial, but its role in
secretion is uncertain. Multiple carriers are available to drive organic
cations uphill into the tubular lumen. The classical system indirectly taps
the energy of the luminal Na gradient to drive organic cation effiux via
Na-H and proton-organic cation exchange. In addition, the multidrug
resistance ATPase can pump organic eations into the tubular lumen. Thus,
although much detailed information has been added over the last 50 years,
it is not yet possible to provide a detailed, quantitative understanding of
these important excretory systems.
The toxic effects of drugs and foreign chemicals are determined
by the duration and level of exposure at critical sites within the
body. Thus, in concert with metabolic oxidation and conjugation,
renal excretion of these agents and their metabolites plays a
critical role in protecting against toxicity. Two secretory transport
systems mediate renal excretion of such compounds, one for
organic anions and another for organic cations. Both systems are
very effective. Indeed, as first documented by Smith 60 years ago
using the anionic dye, phenol red [11, both are capable of
completely clearing a good substrate from the renal plasma in a
single pass through the kidney. Likewise, both systems are able to
transport a very wide range of substrates, requiring only an
appropriate charge on a hydrophobic backbone [21.
Substrates for the organic anion system include a variety of
drugs (penicillins, salicylates) and xenobiotics (phenoxyacetic
herbicides, benzo[a]pyrene) and their metabolites. In addition,
endogenous compounds including neurotransmitter and hormone
metabolites are transported. Substrates for the organic cation
system are similarly diverse, including endogenous compounds
(choline, histamine, serotonin), drugs (antihistaminics, anticholin-
ergics), and xenobiotics (paraquat). As revealed by the detailed
studies of Ulirich, Rumrich and Fritzsch [21, two primary rules
govern interactions with these systems: (1) within a homologous
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series of compounds, the greater the hydrophobicity (octanol/
water partition coefficient) the greater the affinity (that is, the
lower the K1); (2) inhibitory effectiveness increases with increasing
percent ionization. Of course, not all compounds fit these rules
precisely, but many apparent exceptions have simple explanations,
such as hydrophobicity and pK do not necessarily vary indepen-
dently or the effects of hydrophobicity may be limited by steric
factors at the active site. Because these systems mediate the
excretion of so many drugs, competition for excretory transport
can be an important factor in drug interactions, and numerous
such interactions have been described [3].
Clearly, these systems are strategically placed to play vital roles
in response to toxic chemical exposure. In the sections which
follow, we will review current understanding of these transport
systems: (1) briefly summarizing their background, (2) examining




Because a number of well transported organic anions are
intensely colored—thus, easily measured in plasma and urine—
study of their excretion played a prominent role in the develop-
ment of renal physiology. As early as the 1870's, Heidenhain [4]
examined the renal handling and tissue distribution of one such
anion, indigo carmine, and correctly concluded that organic
anions were secreted, that secretion was a function of the proxi-
mal tubule, and that secretion was a two step process with
separate events at the peritubular and luminal faces of the tubule.
These conclusions, which were hotly debated for more than half a
century, were substantiated by Marshall and his collaborators in
the 1920's [51. Soon thereafter, Smith showed that the clearance of
phenol red provided a measure of renal plasma flow and that its
Tm,x could be used as an index for the functional excretory mass
of the kidney [1]. Since Smith's time, the bulk of the effort in this
field has been to provide a mechanistic basis for the extraordinary
capacity of the kidney to secrete organic anions.
General characteristics
From the very first in vitro experiments, it was clear that
maneuvers which compromised cellular energy production, in-
cluding cold, metabolic inhibitors, or anoxia, led to a marked
reduction in organic anion transport [3]. The energetically uphill
step in organic anion secretion must occur at the basolateral
membrane where the negatively charged anion is transported
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Fig. 1. Mechanisms of organic anion (OA; top) and organic cation (OC; bottom) transport in renal proximal tubule. For both classes of solute, lumenal
concentrations exceed cellular, which exceeds that in the extracellular fluid (ECF). Organic anion entry into the cell is driven by indirect coupling to
the Na gradient through Na-divalent organic anion symport (step 1) and organic anion exchange (step 2). Within the cell, organic anions are partitioned
between cytoplasm and vesicles. Exit may occur through facilitated diffusion (step 3). Organic cations enter by PD-driven facilitated diffusion (step 4)
and are taken up from the cytoplasm by endosomes. Organic cation exit is mediated by exchange for protons (step 5) and by the MDR transporter (step
6).
Both sodium removal and ouabain inhibition experiments indi-
cated that this step requires the presence of an out > in Na
gradient [3], suggesting that the basolateral uptake step might be
driven by a Na-organic anion cotransport mechanism. However,
when this possibility was tested in isolated BLM vesicles by Berner
and Kinne [61, direct coupling to sodium could not be demon-
strated. This result led several groups to suggest that organic
anion entry might be coupled to metabolism, perhaps through
exchange for a metabolic intermediate [3], but how such a process
might be energized remained a mystery.
Indirect sodium coupling
These suggestions led Shimada, Moewes and Burckhardt [7]
and Pritchard [8] to propose that organic anions were taken up
across the basolateral membrane in exchange for an anion that
was maintained at a high in > out concentration gradient through
Na cotransport. Based on its abundance in vivo and the impact of
changes in a-ketoglutarate (aKG) concentration and gradient on
organic anion transport in the intact tissue, csKG appears to be the
physiological counterion for organic anion secretion [9]. As
depicted in Figure 1, this is a tertiary active process, coupled to
metabolic energy through two intervening steps. ATP is hydro-
lyzed to drive the Na pump, creating the out> in Na gradient, Na
entry down this gradient drives the uptake of a-ketoglutarate,
creating an in > out aKG gradient, and the organic anion is taken
up in exchange for aKG. Thus, the csKG is recycled and the
overall process yields net uptake of Na and organic anion. As
reviewed recently [3], subsequent intact tissue studies in slices and
isolated tubules not only confirmed the indirect coupling model,
but also demonstrated that increased BLM uptake led to in-
creased transepithelial flux, that is, secretion. Inhibitors of either
organic anion/aKG exchange, such as probenecid, or of Na/aKG
cotransport, such as lithium or fumarate, inhibited the coupled
system. Interestingly, unlike the organic anion site on the ex-
changer which accepts such a broad range of substrates, the
dicarboxylate site is very specific. Only glutarate, suberate, or
adipate can substitute for aKG.
Intracellular events
Secreted anions are not uniformly distributed within the tubular
cells. It has been known for many years that they are subject to
extensive intracellular binding [3]. Recent imaging studies using
fluorescein, a fluorescent organic anion, have shown that intracel-
lular organic anions may also be sequestered within vesicular
structures (Fig. 2) and that sequestration takes place via a
mediated process which was inhibited when p-aminohippurate
(PAH) or probenecid were microinjected into the cells [10]. The
physiological roles of binding and sequestration, if any, remain to
be established. However, two likely possibilities are under study.
First, both processes decrease free cytoplasmic concentrations of
intracellular organic anions during secretion, perhaps reducing
the likelihood of toxicity. Second, intracellular trafficking of
vesicular structures, known to occur in many cell types including
kidney, could play a role in transcellular organic anion movement.
n
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Fig. 2. Fluorescein (FL) compartmentation in cells of crab urinary bladder. Like vertebrate renal proximal tubule, this flat-sheet epithelium secretes
organic anions and organic cations. Shown are transmitted light (A) and epifluorescence micrographs (B) of bladder tissue removed from an animal that
was secreting FL in viva. In both cells, dye is distributed over two compartments, one diffuse and the other punctate. (C) Three-dimensional plot of
fluorescence intensity (z-axis) versus location in the image (xy plane). From Miller et a! [11]; used with permission from the American Journal of
Physiology.
Fluorescein loaded vesicles were shown to move in a basolateral
to apical direction, and this movement was reversibly blocked by
nocodazole, a microtubule depolymerizing drug [11].Nocodazole
also reduced fluorescein secretion in the intact renal tubule [12],
suggesting that vesicular uptake and movement may play a direct
role in transcellular movement and/or luminal exit of secreted
organic anions.
Luminal mechanism
Two potential pathways for exit of secreted organic anions have
been observed in luminal, or brush border, membrane (BBM)
vesicles. In 1980 Blomstedt and Aronson [13] described a luminal
organic anion exchanger which is shared by PAH, lactate, and
urate, as well as several inorganic anions (C1, HCO3 , 0H).
However, this transporter has been found only in urate reabsorb-
ers (dog, rat) and is absent in urate secreters (rabbit, pig) [31.
Since both groups secrete organic anions, this exchanger does not
appear to be an obligatory component of secretion. Furthermore,
the presence of luminal Na/H antiport, which makes the cell
interior more alkaline than tubular fluid, favors reabsorptive
(lumen-to-cell) flux. Thus, it appears that the BBM exchanger
may be more important in urate reabsorption than in organic
anion secretion. Recent studies in both urate secreters (pig) and
reabsorbers (rat) have documented the presence of a probenecid
sensitive, potential driven carrier in the luminal membrane [3, 14].
Given the steep electrochemical gradient favoring effiux of anions
across this membrane, such an electrogenic carrier should be
sufficient to account for luminal flux of secreted organic anions
(Fig. 1). However, when this conclusion was tested directly by
depolarizing intact teleost tubules in elevated external K, or-
ganic anion transport was unchanged, even though transport of an
organic cation decreased in response to decreased electrical
driving force (Fig. 3). Thus, although two mediated routes for
organic anion efflux have been identified in BBM versicles,




All animals studied, from crustaceans and fish to mammals,
have been shown to secrete organic cations [3]. During secretion,
these solutes must cross two hydrophobic membrane barriers and
the intervening aqueous cytoplasm. Data from renal clearance
studies, isolated perfused tubules, and monolayers of proximal
tubule cells indicate that specific, membrane-bound carrier pro-
teins mediate the transport of organic cations across both the
basolateral and luminal membranes of the tubular epithelial cell.
In addition, these studies show that the movement of organic
cations from interstitial fluid to tubular lumen cannot be ex-
plained by passive driving forces, such as simple diffusion, fluid
reabsorption from the lumen, and electrogenic transport driven by
the transepithelial potential difference (PD), which is small in this
"leaky" epithelium. Rather, transepithelial transport of organic
cations is energetically uphill and is disrupted by inhibitors of
metabolism and cellular pH and ion regulation.
In 1979, initial studies of N'-methylnicotinamide (NMN) up-
take in luminal and basolateral membrane vesicles from dog
kidney led Kinsella et al [15] to propose a two step model in which
organic cation secretion was mediated by distinctly different
carriers at each face of the proximal tubule cells. At the basolat-
eral membrane, organic cations entered by facilitated diffusion,
Fig. 3. Effects of membrane depolarization on
steady state distribution of fluorescent solutes in
killifish renal proximal tubules. Raising medium
K from 2.5 (LI) to 25 ()m depolarized by
about 30 mV [18]. High K significantly reduced
accumulation of an organic base, daunomycin.
Transport of daunomycin was measured in the
presence of cyslosporin A to block secretion
through the MDR transporter. High K had no
effects on the accumulation of the organic
anions, fluorescein and carboxyfluorescein,
which was generated intracellularly from
carboxyfluorescein diacetate (CFDA; Miller,
unpublished data). *p < 0.05; < 0.01.
driven by the inside negative transmembrane electrical potential.
Luminal exit was mediated by exchange for other organic cations
or protons (antiport). Additional vesicle studies in several species
soon established that all required elements were present in the
correct locations [3]. However, this model must be modified to
include two new elements: (1) sequestration of organic cations by
intracellular elements, and (2) participation of an ATP-driven
luminal transporter.
Basolateral ently
Studies with BLM vesicles from dog, rat, and rabbit renal cortex
have shown that organic cation uptake is a carrier mediated, but
passive phenomenon, dependent on transmembrane electrical
potential difference [3]. In rabbit renal BLM, a second process
was also found, organic cation exchange. However, it appears that
potential driven organic cation uptake and organic cation ex-
change represent two modes of a single BLM carrier rather than
two carriers with differing energetics [16, 17]. Thus, the vesicle
data are consistent with cellular accumulation of organic cations
being driven primarily by facilitated diffusion (Fig. 1). In intact
renal cells, one should be able to detect electrogenic, facilitated
entiy of organic cations through its dependence on basolateral
membrane PD and by organic cation induced membrane depo-
larization. Smith, Pritchard and Miller [18] measured both baso-
lateral membrane potential and tetraethylammonium (TEA) up-
take in flounder and killifish tubular masses and found that
maneuvers which depolarized the basolateral membrane (high
K, Ba) inhibited TEA uptake and maneuvers that hyperpo-
larized (low K) stimulated uptake. Furthermore, addition of
TEA or darstine to the medium reversibly depolarized the
basolateral membrane potential [18], consistent with electrogenic
uptake of both cations. Likewise, increasing potassium in the
external medium reduces TEA, NMN, and cimetidine uptake by
isolated mammalian proximal tubules, renal cortical slices, and
renal tubules studied in situ, as do reducing medium sodium or
bicarbonate, which also depolarize [3].
Intracellular sequestration
Basolateral PD in proximal tubule cells averages —60 to —80
niV. Therefore, if facilitated diffusion were the only mechanism
contributing to cellular accumulation, one would not expect
tissue-to-medium concentration ratios (T/M) greater than about
10 to 15 for monovalent organic cations. Clearly, facilitated
diffusion by itself cannot account for the high cellular accumula-
tion of TEA found in proximal tubules from rabbit and snake,
where T/M values can exceed 100 [19, 20]. Since no additional
concentrative uptake mechanism has yet been identified, several
workers have suggested that organic cations may be sequestered
intracellularly and, therefore, the average cellular concentration
may overestimate the actual concentration of "free" substrate
within the cytoplasm [3].
Certainly, intracellular binding to cytosolic proteins may con-
tribute to total uptake. Binding is indicated by the frequent
observation that metabolic poisons do not completely eliminate
concentrative uptake of organic cations [3]. A second type of
sequestration, accumulation of organic cations within acidic intra-
cellular organdIes, such as endosomes, lysosomes, and golgi
vesicles, is also likely (Fig. 1). In studies of endosomal membrane
vesicles from rat renal cortex [21], TEA uptake was markedly
stimulated by millimolar concentrations of ATP (Fig. 4). ATP-
dependent TEA uptake was saturable and was inhibited by several
organic cations, including darstine, quinine, and NMN. TEA
uptake was also dependent on low intravesicular pH, maintained
by the H-ATPase on the endosomal membrane. Since TEA is a
quaternary amine, pH trapping could not account for the ATP-
dependent accumulation seen in renal endosomal vesicles, indi-
cating proton-organic cation exchange. Consistent with this inter-
pretation, the ATP requirement could be bypassed by imposing a
pH gradient across the endosome membrane (inside acidic).
Furthermore, TEA and other organic cations accelerated the
dissipation of an ATP-generated pH gradient across the endo-
some membrane [21].
If the capacity of intracellular sites to sequester organic cations
were high enough, TEA activity in the cytoplasm of rabbit and
snake proximal tubule cells might be reduced to a value at or
below its Nernst potential, eliminating the need to postulate an
additional active uptake step at the basolateral membrane. In
addition, it is possible that endosomal sequestration and vectorial
vesicular trafficking play a role in organic cation secretion. In
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Fig. 4. A TP stimulates TEA accumulation by endosomes prepared from rat
renal cortex. Symbols are: (•) 0 [ATP] mM; (LI) 0.2 [ATP] mM; (•) 2
[ATP] mM; (0) 5 [ATP] m. Data are from Pritchard et a! [211; used with
permission of the American Journal of Physiology.
many cells, including renal epithelial cells, there is a continual flux
of membrane-bound organelles from one region to another. If
organic cation-loaded vesicles subsequently fused with the luminal
membrane, organic cations would be released into the tubular
lumen. However, the entire process has yet to be demonstrated in
intact renal cells.
Luminal organic cation/proton exchange
A large body of data for isolated BBM vesicles from dog, rat,
rabbit, human, and snake kidney, as well as for proximal tubule
cell lines show that luminal organic cation transport is mediated
by an electroneutral, organic cation/proton antiporter which can
use potential energy stored in a pH gradient to drive uphill
movement of a variety of cationic substrates (Fig. 1) [3]. Although
BBM vesicles show impressive stimulation of organic cation
transport with investigator-imposed gradients of 1 to 2 pH units
(H activity gradients of 10 to 100), the actual pH gradient across
the luminal membrane of the intact tubule is substantially smaller,
0.5 pH units. This gradient corresponds to a hydrogen ion activity
gradient of only 3.2 and may not be sufficient to account for
luminal organic cation movement against substantial concentra-
tion and electrical gradients. Instead, the luminal antiporter
provides an electroneutral path for organic cation efflux, a path
which bypasses the electrical potential barrier at the luminal
membrane. The price paid for this benefit would be increased
Na/H exchange to restore the luminal pH gradient, and
ultimately, increased ATP hydrolysis to maintain the out > in
Na gradient.
Multidrug resistance transporter
One important mechanism by which some tumor cells develop
resistance to chemotherapeutic agents is to express a plasma
membrane-bound ATPase that pumps drugs out of the cell, This
multidrug transporter (called MDR, p-glycoprotein, or gp-170)
exhibits a broad substrate specificity, handling calcium channel
blockers, anthracyclines, Vinca alkaloids, calmodulin antagonists,
steroids, cyclosporins, and miscellaneous hydrophobic organic
cations [22]. Normal tissues also express MDR and proximal
tubule, in particular, contains high levels. In proximal tubule,
MDR is localized to the luminal membrane, where it could pump
xenobiotics into the lumen (Fig. 1) [23, 24]. In this regard, recent
imaging studies have demonstrated active secretion of a fluores-
cent cyclosporine A (C5A) derivative and of the fluorescent
anthracycline, daunomycin, into the lumen of intact teleost (killi-
fish) renal proximal tubules [25, 26]. In both cases, transport from
cell to tubular lumen was reduced by several p-glycoprotein
substrates, including CSA and verapamil, and by vanadate, a
potent inhibitor of the MDR transporter. In the case of the weak
organic base, daunomycin, transport was mediated by both the
MDR transporter and the classical organic cation transport
system, with partitioning between the two being pH-dependent.
Perspectives
This review provides numerous instances where understanding
of the individual cellular processes mediating renal secretion has
increased thanks to technical advances in the study of transport
mechanisms. For example, just a decade ago, we were unaware of
basolateral indirect sodium-coupled uptake of organic anions,
vesicle-mediated transport of both organic anions and cations,
and MDR transporter-mediated organic cation secretion into the
lumen. Nevertheless, as pointed out above, much remains to be
worked out.
Two areas which were not discussed above are particularly
interesting and potentially important. First, little is known about
the regulation of organic anion and cation transport in the kidney
or in extrarenal epithelia. Recent reports from one laboratory
implicate the protein kinase C system in control of PAH and TEA
uptake by rabbit proximal tubules [27, 28]. Although receptors for
several hormones acting through that signalling system, such as
PTH and endothelin, have been localized to proximal tubule, at
present it is not clear which physiological stimuli might affect
secretion. Second, molecular biological techniques are just begin-
fling to bear fruit. In the past year one of the transport proteins
involved, a PD-dependent carrier for organic cations (OCT1), was
cloned and sequenced [29]. However, none of the transporters for
monovalent organic anions have been cloned. Once the individual
transporters are cloned and sequenced, the primary structure of
the proteins may be deduced and probes prepared for study of
transporter production and control. Thus, molecular biology can
pay large dividends in areas where we currently have little
information, such as structure-function relationships for the trans-
porters and their physiological and/or pharmacological regulation.
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